Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06606171 · ClinicalTrials.gov registry record · NA

Floor Sitting Study

A NA study of Sedentary Behaviors and Posture, sponsored by Beth Pyatak.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06606171: Recruiting NA study of Sedentary Behaviors and Posture, sponsored by Beth Pyatak.

NCT06606171 is a NA study of Sedentary Behaviors and Posture that is actively recruiting participants, run by Beth Pyatak. The registered enrollment target is 40 participants, below the 52-participant average among 4 other Sedentary Behaviors trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06606171, a NA study of Sedentary Behaviors and Posture, is actively recruiting participants, sponsored by Beth Pyatak.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate the impact of different sitting environments on general well-being and movement patterns in healthy young adults aged 18-35. The main questions it aims to answer are: Does floor sitting lead to increased movement and postural changes compared to chair sitting? Over a month-long period, how does sustained floor sitting influence overall well-being, posture, and movement habits? Researchers will compare the effects of chair sitting and floor sitting in a controlled lab environment (Aim 1) and observe the longer-term effects of habitual floor sitting in participants natural environments (Aim 2) to see if consistent floor sitting promotes more dynamic movement and comfort. Participants will: Undergo two 30-minute experimental sitting sessions, one in a chair and the other on the floor, while engaging in typical desk activities (Aim 1). Participate in a month-long study where they integrate an hour of floor sitting into their daily routines, recording their experiences and any changes in sitting habits through daily diaries and in-depth interview (Aim 2).

Primary Outcome

Measurement of movement patterns using accelerometry to assess changes in physical activity levels and subtle movements, including frequency, intensity, and duration of movements during different sitting interventions (chair vs. floor sitting).

Interventions

  • BEHAVIORAL Chair Sitting (30 minutes)
  • BEHAVIORAL Floor Sitting (30 minutes)
  • BEHAVIORAL Daily Floor Sitting Practice (1 month)

Study Locations (1)

California

  • Lifestyle Redesign for Chronic Conditions Lab - Los Angeles

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-10-25
Est. Completion 2025-03-30
Phase NA
Beth Pyatak

1 total trials

What NCT06606171 shows while recruiting

NCT06606171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 52-participant average among 4 other Sedentary Behaviors trials with a reported enrollment target (23% lower).

The record links to 3 conditions, with Sedentary Behaviors appearing as the primary indexed condition, and to 3 interventions - of which Chair Sitting (30 minutes) is the first listed.

NCT06606171 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06606171 about?

NCT06606171 is a clinical study titled "Floor Sitting Study". The goal of this clinical trial is to evaluate the impact of different sitting environments on general well-being and movement patterns in healthy young adults aged 18-35. The main questions it aims to answer are: Does floor sitting lead to increased movement and postural changes compared to chair ...

What is the current status of trial NCT06606171?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-10-25. Estimated completion is 2025-03-30.

What conditions does trial NCT06606171 study?

This clinical trial studies the following conditions: Sedentary Behaviors, Posture, Well-being/Quality of Life.

What interventions are being tested in trial NCT06606171?

The interventions under investigation include: Chair Sitting (30 minutes) (BEHAVIORAL), Floor Sitting (30 minutes) (BEHAVIORAL), Daily Floor Sitting Practice (1 month) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06606171?

This trial is sponsored by Beth Pyatak, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06606171 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sedentary Behaviors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06606171, the US trial registry maintained by the National Library of Medicine. NCT06606171 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.